SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001047469-16-014777
Filing Date
2016-08-08
Accepted
2016-08-08 14:00:56
Documents
18

Document Format Files

Seq Description Document Type Size
1 424B4 a2229387z424b4.htm 424B4 2343607
2 G342833.JPG g342833.jpg GRAPHIC 12219
3 G433713.JPG g433713.jpg GRAPHIC 81167
4 G244864.JPG g244864.jpg GRAPHIC 73901
5 G1031628.JPG g1031628.jpg GRAPHIC 58535
6 G251333.JPG g251333.jpg GRAPHIC 76270
7 G146740.JPG g146740.jpg GRAPHIC 67325
8 G805213.JPG g805213.jpg GRAPHIC 131333
9 G667216.JPG g667216.jpg GRAPHIC 368
10 G640635.JPG g640635.jpg GRAPHIC 60258
11 G864922.JPG g864922.jpg GRAPHIC 54417
12 G612051.JPG g612051.jpg GRAPHIC 56098
13 G419181.JPG g419181.jpg GRAPHIC 46733
14 G197595.JPG g197595.jpg GRAPHIC 35644
15 G363356.JPG g363356.jpg GRAPHIC 29096
16 G395948.JPG g395948.jpg GRAPHIC 47088
17 G95314.JPG g95314.jpg GRAPHIC 137815
18 G684562.JPG g684562.jpg GRAPHIC 82357
  Complete submission text file 0001047469-16-014777.txt   3793622
Mailing Address 43334 7 MILE ROAD SUITE 1000 NORTHVILLE MI 48167
Business Address 43334 7 MILE ROAD SUITE 1000 NORTHVILLE MI 48167 248-980-6538
Gemphire Therapeutics Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-210815 | Film No.: 161813651
SIC: 2834 Pharmaceutical Preparations